​

Funding Round

Series A - Cardea Bio

Series A - Cardea Bio

Investment Firm

Overview

Cardea is developing a new generation of (bio)technology infrastructure based on proprietary biology-gated transistors.

Announced Date

Sep 17, 2020

Closed on Date

Sep 17, 2020

Funding Type

Series A

Highlights

Location

United States, North America

Social

Investor Lead

Serra Ventures

Serra Ventures

Serra Ventures is a early_stage_venture and seed and venture firm.

Participant Investors

6

Investor Name
Participant InvestorTaihill Venture
Participant InvestorPhoton Fund
Participant InvestorTable Mountain Ventures
Participant InvestorAgilent Technologies
Participant InvestorSerra Ventures

Round Details and Background

Cardea Bio raised $7500000 on 2020-09-17 in Series A

Cardea is developing a new generation of (bio)technology infrastructure based on proprietary biology-gated transistors.

Company Funding History

7

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
May 04, 2015
Seed Round - Cardea Bio
1-1.1M
Jan 12, 2021
Series A - Cardea Bio
2-6.5M
Oct 23, 2020
Convertible Note - Cardea Bio
1-undefined
May 03, 2022
Grant - Cardea Bio
1-1.1M

Recent Activity

There is no recent news or activity for this profile.